By Denny Jacob
MeiraGTx Holdings shares rose 13% in premarket trading on a collaboration with Hologen that will bring in a cash infusion and create a joint venture.
Shares were trading around $7.28. The stock is up 8.6% over the last year.
MeiraGTx will receive $200 million as part of the collaboration. The two sides will also form a JV called Hologen Neuro AI, which will be funded with committed of up to $230 million from Hologen to fully finance the development of a treatment for Parkinson's disease, among other efforts.
MeiraGTx will retain a 30% stake in the joint venture and will lead all clinical development and manufacturing.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
March 13, 2025 08:11 ET (12:11 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。